Company Profile
Updated: 09-SEP-09Per-Tech Inc.
Private Company, Headquarters Location
113 Erie St. S, Massillon, OH 44646, United States
(330)833-8824, (330)833-5004 fax,
Primary SIC: Electronic Components, Not Elsewhere Classified, Primary NAICS: Other Electronic Component Manufacturing
Description: Manufacturing: Manufactures electronic cable and wire harness assemblies; manufactures electrical equipment for engines
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Intelligroup Q3 EPS Rise to $0.09 versus $0.06 on 330 Basis Point Gross Margin Improvement.
Investment Weekly News; 11/21/2009; 1185 words; Intelligroup, Inc. (OTC BB: ITIG...million, or $0.09 per diluted share, compared...million, or $0.08 per diluted share, in...million, or $0.06 per diluted share, in...Manufacturing and High-Tech." Additional Q3...Keywords: Intelligroup, Inc., Technology, Data...
Investor Savings Crosses $7 Million Mark with XpressRouter Technology Exclusively Available from optionsXpress.
Investment Weekly News; 11/21/2009; 1091 words; ...optionsXpress Holdings, Inc. (Nasdaq: OXPS) announced...sometimes offer rock-bottom per-trade rates but then...optionsXpress Holdings, Inc. optionsXpress Holdings...Trade Experience; Trade Tech; Usability; Offerings...trading. optionsXpress, Inc. makes no investment recommendations...
Groupe Aeroplan to Acquire Carlson Marketing.
Biotech Week; 11/18/2009; 1271 words; ...with Carlson Companies, Inc. (CCI) to purchase Carlson...see also Groupe Aeroplan Inc.). Carlson Marketing...services, automotive, high tech, consumer packaged goods...earnings and free cash flow per share as Carlson Marketing...Keywords: Groupe Aeroplan Inc., Acquisitions, Advertising...
Sucampo Pharmaceuticals Reports Financial Results for the Third Quarter of 2009.(Financial report)
Biotech Week; 11/18/2009; 1460 words; ...Sucampo Pharmaceuticals, Inc.). Net sales of Amitiza...1 million, or $0.00 per diluted share, in the...4 million, or $0.06 per diluted share, in the...3.0 million to R-Tech Ueno Ltd. for the U...Sucampo Pharmaceuticals, Inc. announced that William...
CPEX's Nasulin Insulin Therapy Featured in an Oral Presentation and Four Abstracts at the Ninth Annual Diabetes Technology Meeting.(Clinical report)
Clinical Trials Week; 11/16/2009; 1721 words; CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) announced...of up to 200 microliters per nostril was well tolerated...CPEX Pharmaceuticals, Inc.). Dr. Berman commented...Berkeley, the Georgia Tech/Emory Center for Engineering...CPEX Pharmaceuticals, Inc. is an emerging specialty...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning